These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 35482841)

  • 1. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Huston JH; Shah SJ
    Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension associated with left heart disease.
    Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
    Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary hypertension associated with left heart disease (group 2)].
    Wissmüller M; Tichelbäcker T; Finke K; Dohr J; Adler J; Ochs L; Hohmann C; Baldus S; Rosenkranz S
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1498-1506. PubMed ID: 37949078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
    van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
    Kido K; Coons JC
    Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
    Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
    Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
    Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
    Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hypertension – a common condition in left heart disease].
    Lundgren J; Rådegran G
    Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biological Bases of Group 2 Pulmonary Hypertension.
    Fernández AI; Yotti R; González-Mansilla A; Mombiela T; Gutiérrez-Ibanes E; Pérez Del Villar C; Navas-Tejedor P; Chazo C; Martínez-Legazpi P; Fernández-Avilés F; Bermejo J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of pulmonary hypertension due to left heart disease.
    Liu SF; Yan Y
    Animal Model Exp Med; 2022 Sep; 5(3):197-206. PubMed ID: 35234367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease.
    Ilonze OJ; Ebong IA; Guglin M; Nair A; Rich J; McLaughlin V; Tedford RJ; Mazimba S
    JACC Heart Fail; 2024 Aug; 12(8):1328-1342. PubMed ID: 38970588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
    Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N
    Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Pulmonary Hypertension in Left Heart Disease.
    Macera F; Vachiéry JL
    Methodist Debakey Cardiovasc J; 2021; 17(2):115-123. PubMed ID: 34326931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
    Hunt JM; Bethea B; Liu X; Gandjeva A; Mammen PP; Stacher E; Gandjeva MR; Parish E; Perez M; Smith L; Graham BB; Kuebler WM; Tuder RM
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L725-36. PubMed ID: 24039255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
    J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of pulmonary hypertension caused by left heart disease.
    Xiao M; Lai D; Yu Y; Wu Q; Zhang C
    Front Cardiovasc Med; 2023; 10():1079142. PubMed ID: 36937903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.